REVascularisation for Ischaemic VEntricular Dysfunction
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Antithrombotics
- Indications Coronary artery disease; Embolism and thrombosis; Left ventricular dysfunction
- Focus Therapeutic Use
- Acronyms REVIVED
- 01 Sep 2021 Biomarkers information updated
- 27 Dec 2012 New trial record